logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hengrui Medicine (01276.HK) spent 15.0888 million yuan on July 17 to repurchase 280,000 A shares.

date
17/07/2026
The Zhitong Finance and Economics APP News reports that Hengrui Medicine (01276.HK) announced that on July 17, 2026, the company spent 15.0888 million yuan to repurchase 280,000 A-shares.
Latest
1 m ago
Shanxi Expressway: A related transaction of 65.76 million yuan was formed through open bidding.
1 m ago
Delis: Revenue of 3.147 billion yuan in 2025, with a net loss of 10.3023 million yuan.
2 m ago
China Electric Huada Technology (00085.HK) appoints Fan Heng as independent non-executive director.
2 m ago
Yuantong Express: In June, the express delivery business completed a volume of 2.853 billion tickets, a year-on-year increase of 8.57%, with revenue of 5.883 billion yuan, a year-on-year increase of 6.44%.
2 m ago
This week, the Shanghai Stock Exchange has taken self-regulatory measures against 157 cases of price manipulation, false declaration, and other abnormal securities trading behaviors.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.